Mammary Cell News 11.48 December 12, 2019 | |
| |
TOP STORYSelective targeting of CCR2 in the PyVmT mammary epithelium inhibited tumor growth and invasion, elevated CD8+ T cells, decreased M2 macrophages and decreased angiogenesis. Co-culture models demonstrated these stromal cell responses were mediated by tumor-derived CCL2 and CCR2-mediated suppression of the T-cell activating cytokine, CD154. [Oncogene] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists identified a novel splice variant of metadherin with exon7 skipping (MTDHΔ7) and its levels were found to be significantly high in triple negative breast cancer (TNBC) cells and in patients diagnosed with TNBC. [Oncogene] Abstract Investigators determined whether intra-mitochondrial Src (mtSrc) kinase had specific impact on breast cancer cells. They observed that activity of mtSrc was higher in breast cancer cells of the triple negative subtype. [Cell Death Dis] Full Article The authors demonstrated that miR-137 exerted a significant effect on repressing the development of chemoresistance of breast cancer cells in response to doxorubicin via attenuating epithelial-mesenchymal transition of tumor cells in vitro and in vivo. [Cell Death Dis] Full Article In vitro assays showed that, in contrast to previous studies in models of normal cells, metformin reduced fatty acid oxidation with a subsequent accumulation of intracellular triglyceride, independent of AMPK activation. [Br J Cancer] Full Article Researchers showed that aconitase 2 levels were decreased in breast cancer cell lines and human tumour biopsies. They generated ACO2- overexpressing MCF-7 cells and employed comparative analyses to identify metabolic adaptations. [Br J Cancer] Abstract LncRNA MACC1-AS1 Sponges Multiple miRNAs and RNA-Binding Protein PTBP1 Scientists report that MACC1-AS1, a cognate antisense long noncoding RNA of the sixth intron of the MACC1 gene, functioned as a cell growth modulator and enhanced breast tumor progress. [Oncogenesis] Full Article Researchers showed that reducing the expression of voltage-gated sodium channel (NaV)1.5 in highly aggressive human MDA-MB-231 breast cancer cells reverted the mesenchymal phenotype, reduced cancer cell invasiveness and the expression of the epithelial-to-mesenchymal transition-promoting transcription factor SNAI1. [Sci Rep] Full Article Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells Investigators showed that lower doses of thioridazine targeted the self-renewal of basal-like breast cancer cells, but not breast cancer cells of other subtypes. [Sci Rep] Full Article Novel Function of ∆Np63 in Cell Polarity and Metabolism in Pubertal Mammary Gland Development The authors demonstrated that deletion of ∆Np63 at puberty resulted in depletion of mammary stem cell-enriched basal cells, reduced expression of E-cadherin and β-catenin, and led to a closed ductal lumen. [FEBS Lett] Abstract Subscribe to one of our other 19 science newsletters such as Prostate Cell News & ESC & iPSC News. | |
| |
REVIEWSTransient Receptor Potential Cation Channel Subfamily V and Breast Cancer Scientists provided an overview of transient receptor potential cation channel subfamily V (TRPV) expression in breast cancer subtypes, the roles of TRPV channels in various aspects of breast cancer progression and consider implications for future therapeutic approaches. [Lab Invest] Abstract Visit our reviews page to see a complete list of reviews in the mammary cell research field. | |
| |
INDUSTRY NEWSNeuClone Pharmaceuticals Ltd announced that NeuCeptin, a biosimilar candidate of Herceptin®, has successfully met all primary and secondary endpoints in a Phase I clinical trial. [NeuClone Pharmaceuticals Ltd] Press Release The National Comprehensive Cancer Network® Oncology Research Program announced the proposals that were selected to receive funding, in collaboration with Pfizer Global Medical Grants, to improve the quality of care and outcomes for people with metastatic breast cancer. [The National Comprehensive Cancer Network] Press Release | |
| |
POLICY NEWSKU Leuven Investigates Whether Stem Cell Scientist Falsified Data KU Leuven is investigating allegations that one of its researchers, acclaimed stem cell biologist Catherine Verfaillie, was involved in falsifying research in at least 10 scientific papers published between 1999 and 2018, Belgian newspaper De Tijd reported last week. [The Scientist] Editorial Congress Set to Form Groups to Protect US Research Security Congress is expected to approve an annual defense bill as early as this week that would create two federal bodies aimed at preventing foreign government influence in scientific research. [The Scientist] Editorial US Scientists Who Hide Foreign Ties Should Face Research Misconduct Sanctions, Panel Says US scientists who violate government rules on disclosing foreign research ties should be investigated for research misconduct, says an independent group of prominent scientists asked to examine the threat of foreign influences on the US research enterprise. [ScienceInsider] Editorial
| |
EVENTSNEW 4th DNA Repair/Replication Structures and Cancer Conference Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Leader – Breast Cancer Program (Fred Hutchinson Cancer Research Center) NEW Postdoctoral Training Fellow – Molecular Oncology (Institute of Cancer Research) NEW Postdoctoral Position – Fibroblasts in Breast Cancer (Institut Curie) Postdoctoral Fellowship – Molecular Mechanisms in Cancers (Cleveland Clinic) Junior Group Leader – Bioinformatics in Translational Cancer Research (Mildred Scheel Career Center) Senior/Research Associate – In Vivo Pharmacology for Oncology Research (Moderna) Postdoctoral Fellow – Breast Cancer Stem Cells (Dalhousie University) Research Scholar – Breast Cancer (Eastern Virginia Medical School) Postdoctoral Scholar – Breast Cancer (The University of Kentucky) Postdoctoral Researcher – Breast and Ovarian Cancer (Curtin University) Postdoctoral Associate – Immune Responses (The Jackson Laboratory) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mammary Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|